Insider Transactions in Q4 2020 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2020
|
Mark Guinan Executive Vice President & CFO |
SELL
Open market or private sale
|
Direct |
81,756
-30.79%
|
$9,810,720
$120.62 P/Share
|
|
Dec 24
2020
|
Mark Guinan Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,756
+34.48%
|
$5,395,896
$66.51 P/Share
|
|
Nov 24
2020
|
Gail R Wilensky Director |
SELL
Open market or private sale
|
Direct |
6,111
-27.05%
|
$769,986
$126.02 P/Share
|
|
Nov 24
2020
|
Gail R Wilensky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,111
+21.29%
|
$348,327
$57.66 P/Share
|
|
Nov 23
2020
|
Daniel Stanzione Director |
SELL
Open market or private sale
|
Direct |
11,223
-10.48%
|
$1,414,098
$126.55 P/Share
|
|
Oct 21
2020
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Open market or private sale
|
Direct |
10,450
-15.99%
|
$1,306,250
$125.0 P/Share
|
|
Oct 21
2020
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,450
+13.8%
|
$595,650
$57.21 P/Share
|
|
Oct 16
2020
|
Stephen H Rusckowski Director |
SELL
Open market or private sale
|
Direct |
291,997
-55.12%
|
$35,039,640
$120.0 P/Share
|
|
Oct 16
2020
|
Stephen H Rusckowski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
291,997
+35.53%
|
$19,271,802
$66.51 P/Share
|
|
Oct 14
2020
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
35,591
-47.03%
|
$4,235,329
$119.0 P/Share
|
|
Oct 14
2020
|
Michael E Prevoznik SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
35,591
+31.99%
|
$1,850,732
$52.16 P/Share
|
|
Oct 06
2020
|
Manuel O. Mendez SVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,871
-19.67%
|
$669,294
$114.01 P/Share
|